UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Invst LLC

Invst LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 20.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,510 shares of the healthcare conglomerate’s stock after purchasing an additional 252 shares during the period. Invst LLC’s holdings in UnitedHealth Group were worth $747,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Covington Investment Advisors Inc. grew its stake in shares of UnitedHealth Group by 2.5% during the 2nd quarter. Covington Investment Advisors Inc. now owns 25,602 shares of the healthcare conglomerate’s stock worth $13,038,000 after purchasing an additional 627 shares during the period. Second Line Capital LLC lifted its position in shares of UnitedHealth Group by 9.1% during the 2nd quarter. Second Line Capital LLC now owns 4,798 shares of the healthcare conglomerate’s stock valued at $2,444,000 after acquiring an additional 402 shares during the period. Wallace Advisory Group LLC grew its holdings in shares of UnitedHealth Group by 1.1% in the 2nd quarter. Wallace Advisory Group LLC now owns 2,788 shares of the healthcare conglomerate’s stock worth $1,420,000 after acquiring an additional 29 shares during the period. William B. Walkup & Associates Inc. purchased a new stake in UnitedHealth Group during the second quarter worth $5,223,000. Finally, Front Row Advisors LLC increased its position in shares of UnitedHealth Group by 12.4% in the second quarter. Front Row Advisors LLC now owns 181 shares of the healthcare conglomerate’s stock valued at $92,000 after buying an additional 20 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $584.68 on Tuesday. The firm has a market capitalization of $539.91 billion, a PE ratio of 35.74, a P/E/G ratio of 1.62 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $607.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The business has a 50-day moving average of $579.93 and a two-hundred day moving average of $525.06.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same period in the previous year, the company posted $6.14 earnings per share. UnitedHealth Group’s revenue was up 6.4% compared to the same quarter last year. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.44%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

Analyst Ratings Changes

Several equities analysts have weighed in on UNH shares. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and raised their target price for the company from $481.00 to $647.00 in a report on Wednesday, July 17th. UBS Group increased their target price on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a report on Thursday, July 18th. Robert W. Baird upped their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, September 25th. Finally, TD Cowen lifted their price target on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $614.17.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.